| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.8 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.9 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.0098 | 0.9 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.0098 | 0.9 |